Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01056432 · ClinicalTrials.gov registry record

Bone UltraSonic Scanner (BUSS) Clinical Optimization Study

A clinical trial, sponsored by Artann Laboratories.

Completed
Registry status
100
Enrollment target

NCT01056432 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01056432 has completed, sponsored by Artann Laboratories.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

The aim of this clinical study using Bone UltraSonic Scanner (BUSS) is to obtain clinical data which will help to optimize the BUSS examination procedure and its diagnostic algorithms for assessment of bone conditions.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2010-01
Est. Completion 2011-01

Sponsor

Artann Laboratories

14 total trials

What the Registry Record Tells You About NCT01056432

The ClinicalTrials.gov registry entry for NCT01056432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Artann Laboratories, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01056432 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01056432 about?

NCT01056432 is a clinical study titled "Bone UltraSonic Scanner (BUSS) Clinical Optimization Study". The aim of this clinical study using Bone UltraSonic Scanner (BUSS) is to obtain clinical data which will help to optimize the BUSS examination procedure and its diagnostic algorithms for assessment of bone conditions.

What is the current status of trial NCT01056432?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2010-01. Estimated completion is 2011-01.

Who is sponsoring clinical trial NCT01056432?

This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.